Literature DB >> 26298724

MicroRNA-148a inhibits migration of breast cancer cells by targeting MMP-13.

Jinqi Xue1, Zhiguang Chen2, Xi Gu1, Yang Zhang1, Wenhai Zhang3.   

Abstract

Breast cancer is a threat to the health of women, and metastasis of breast cancer cells plays an important role in the deterioration of breast cancer. MicroRNAs play a critical role in the tumorigenesis and development of breast cancer. MicroRNA-148a (miR-148a) is associated with the growth and metastasis of tumor cells. In the present study, we investigated the role of miR-148a in migration of breast cancer cells as well as the underlying mechanism. MiR-148a was found to inhibit the proliferation and migration of breast cancer cells. To further explore the mechanism through which miR-148a plays its antitumor role, matrix metalloproteinase-13 (MMP-13) was identified as a target of miR-148a by western blot and luciferase reporter assay. Moreover, silence of MMP-13 mimicked the effect of miR-148a, whereas overexpression of MMP-13 rescued the impaired migration caused by miR-148a. Our study demonstrates that miR-148a inhibits the migration of breast cancer cells by targeting MMP-13 and also lays theoretical foundation for further exploration for the function of miR-148a.

Entities:  

Keywords:  Breast cancer cells; MMP-13; MiR-148a; Migration

Mesh:

Substances:

Year:  2015        PMID: 26298724     DOI: 10.1007/s13277-015-3926-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

1.  MicroRNA-148a inhibits migration and invasion of ovarian cancer cells via targeting sphingosine-1-phosphate receptor 1.

Authors:  Zhengfang Wen; Shuzhen Zhao; Shanshan Liu; Ying Liu; Xiaorui Li; Shaoru Li
Journal:  Mol Med Rep       Date:  2015-05-25       Impact factor: 2.952

2.  MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.

Authors:  J-P Zhang; C Zeng; L Xu; J Gong; J-H Fang; S-M Zhuang
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

3.  MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B.

Authors:  Sven-T Liffers; Johanna B Munding; Markus Vogt; Jan D Kuhlmann; Berlinda Verdoodt; Sandeep Nambiar; Abdelouahid Maghnouj; Alireza Mirmohammadsadegh; Stephan A Hahn; Andrea Tannapfel
Journal:  Lab Invest       Date:  2011-06-27       Impact factor: 5.662

4.  Matrix metalloproteinases: biologic activity and clinical implications.

Authors:  A R Nelson; B Fingleton; M L Rothenberg; L M Matrisian
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

5.  MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.

Authors:  Biqiang Zheng; Linhui Liang; Chunmeng Wang; Shenglin Huang; Xi Cao; Ruopeng Zha; Li Liu; Deshui Jia; Qi Tian; Jianghong Wu; Yanwei Ye; Qifeng Wang; Ziwen Long; Ye Zhou; Chunyan Du; Xianghuo He; Yingqiang Shi
Journal:  Clin Cancer Res       Date:  2011-10-12       Impact factor: 12.531

6.  microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.

Authors:  Jungeun Kim; Ying Zhang; Michael Skalski; Josie Hayes; Benjamin Kefas; David Schiff; Benjamin Purow; Sarah Parsons; Sean Lawler; Roger Abounader
Journal:  Cancer Res       Date:  2014-01-14       Impact factor: 12.701

7.  microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition.

Authors:  Sui-Han Wang; Xu Li; Li-Sheng Zhou; Zhong-Wei Cao; Chao Shi; Chong-Zhi Zhou; Yu-Gang Wen; Yang Shen; Ji-Kun Li
Journal:  Tumour Biol       Date:  2013-07-20

8.  Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis.

Authors:  Nathan E Hellman; June Spector; Jonathan Robinson; Xiaofeng Zuo; Sophie Saunier; Corinne Antignac; John W Tobias; Joshua H Lipschutz
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

9.  Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer.

Authors:  M F Leeman; J A McKay; G I Murray
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

10.  Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues.

Authors:  Linjiang Pan; Suning Huang; Rongquan He; Minhua Rong; Yiwu Dang; Gang Chen
Journal:  Eur J Med Res       Date:  2014-12-02       Impact factor: 2.175

View more
  15 in total

1.  Parathyroid hormone-induced down-regulation of miR-532-5p for matrix metalloproteinase-13 expression in rat osteoblasts.

Authors:  Vishal Mohanakrishnan; Arumugam Balasubramanian; Gokulnath Mahalingam; Nicola Chennell Partridge; Ilangovan Ramachandran; Nagarajan Selvamurugan
Journal:  J Cell Biochem       Date:  2018-04-06       Impact factor: 4.429

2.  Tumor-suppressive microRNA-452 inhibits migration and invasion of breast cancer cells by directly targeting RAB11A.

Authors:  Wanjun Li; Guoyin Li; Zhigang Fan; Tao Liu
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

Review 3.  Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.

Authors:  Fu Peng; Liang Xiong; Hailin Tang; Cheng Peng; Jianping Chen
Journal:  Tumour Biol       Date:  2016-09-19

4.  MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3.

Authors:  Jianwei Liu; Libo Si; Hui Tian
Journal:  Exp Ther Med       Date:  2018-10-11       Impact factor: 2.447

5.  Depletion of tumor suppressor miRNA-148a in plasma relates to tumor progression and poor outcomes in gastric cancer.

Authors:  Shuhei Komatsu; Taisuke Imamura; Jun Kiuchi; Yusuke Takashima; Hajime Kamiya; Takuma Ohashi; Hirotaka Konishi; Atsushi Shiozaki; Takeshi Kubota; Kazuma Okamoto; Eigo Otsuji
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

6.  miR-148a Suppresses estrogen-induced viability and migration of breast cancer cells via inhibition of estrogen receptor α expression.

Authors:  Fang Ma; Yeqian Feng; Weihui Li; Zexuan Li; Tiebang Liu; Lingjiang Li
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

7.  The role of microRNAs in gallbladder cancer.

Authors:  Ganghua Yang; Lei Zhang; Ruixiang Li; Lin Wang
Journal:  Mol Clin Oncol       Date:  2016-05-11

8.  MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells.

Authors:  Wen-Dong Ruan; Pei Wang; Shiqing Feng; Yuan Xue; Bin Zhang
Journal:  Onco Targets Ther       Date:  2016-01-18       Impact factor: 4.147

9.  Stable duplex-linked antisense targeting miR-148a inhibits breast cancer cell proliferation.

Authors:  Sho Okumura; Yu Hirano; Yasuo Komatsu
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

10.  miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients.

Authors:  Nesreen G Elhelbawy; Ibrahim F Zaid; Aya A Khalifa; Suzy F Gohar; Eman A Fouda
Journal:  Biochem Biophys Rep       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.